Intent to Increase ceiling for FDA IDIQ CONTRACT 75F40124D00020 by $50,000,000.00 from $99,880,020.00 to $149,880,020.00

The U.S. Food and Drug Administration intends to increase the ceiling value of Contract 75F40124D00020 by $50,000,000, raising it from $99,880,020 to $149,880,020, to accommodate expanded scientific support needs under the Sentinel 3.0 Tier 8 requirement and increased utilization of the contract. This sole source modification applies to Vets Synergetic Group LLC, the current awardee, and does not alter the existing scope, nature of work, or contract terms; all future work will continue to be executed through task orders within the established framework. The contract, set to expire on June 9, 2028, is being adjusted to ensure sufficient funding is available to issue additional orders before termination. The action falls under the 8A set-aside program for small businesses and is managed by the FDA Negotiated Contracts Branch within the Department of Health and Human Services. The place of performance is in Silver Spring, Maryland, with points of contact at the agency’s Rockville, Maryland office. This notice serves solely as a public announcement and is not an invitation for proposals or submissions.